WHO Reports Highest AMR in Countries with Weakest Health Systems
Okay, here’s a breakdown of the provided text, summarizing the key details about the WHO’s 2025 GLASS report on antimicrobial resistance (AMR):
Key Findings & Concerns:
* Growing Threat: the WHO identifies AMR, especially in Gram-negative bacteria, as a major and increasing global health threat. it compromises the effectiveness of treatments and undermines modern medicine.
* Increased Participation in Surveillance: More countries (a four-fold increase since 2016) are participating in the Global Antimicrobial Resistance and Use Surveillance System (GLASS), allowing for better global estimates.
* Rising Resistance Rates: Despite increased surveillance, AMR is increasing. 40% of monitored pathogen-antibiotic combinations showed increased resistance between 2018-2023.
* Specific Pathogens of Concern: resistance is notably increasing to carbapenems and fluoroquinolones in key Gram-negative pathogens: Acinetobacter spp.,E. coli, K. pneumoniae, and Salmonella spp. These antibiotics are crucial for severe infections.
* Treatment implications: Rising AMR is limiting treatment options,pushing for more intravenous treatments and reliance on last-resort antibiotics.
Underlying Factors & Disparities:
* Socioeconomic Factors: The report links AMR burden to socioeconomic factors and the strength of a country’s health system.
* Inverse Correlation: There’s a strong inverse correlation between worldwide health coverage access and income, and the percentage of AMR in bloodstream infections. (Wealthier countries with better healthcare have lower AMR rates).
* Syndemic: The situation is described as a “syndemic,” meaning AMR disproportionately affects countries with weaker health systems and lower incomes.
* Surveillance Gaps: Countries with limited surveillance often have higher resistance levels, highlighting the need for improved laboratory and data systems in under-resourced regions.
“What You Need to Know” summary (from the sidebar):
* AMR, particularly in E. coli, K.pneumoniae, and Acinetobacter, is continuing to rise.
* Resistance increased in 40% of pathogen-antibiotic combinations between 2018 and 2023.
In essence, the report paints a concerning picture of a growing AMR crisis, exacerbated by global inequalities in healthcare access and resources. increased surveillance is helpful, but addressing the underlying socioeconomic factors and strengthening health systems in vulnerable countries are crucial to combatting this threat.